Abstract
Receptors are prevalent drug targets as they translate signals from outside the cell to cellular reactions. In drug finding and characterization it is not only required to measure ligand binding, but just as well subsequent regulatory steps including desensitizing protein interactions. Here, we show how CRISPR/Cas9 allowed endogenous expression of a G-protein coupled receptor (GPCR) and how that was used to study protein inter - actions and internalization of a cancer progressing receptor.
This is a preview of subscription content, log in via an institution to check access.
References
Sriram K, Insel PA (2018) GPCRs as targets for approved drugs: How many targets and how many drugs? Mol Pharmacol 93:251–258
Sun X, Cheng G, Hao M et al. (2010) CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29:709–722
White CW, Vanyai HK, See HB et al. (2017) Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time. Sci Rep 7:3187
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krumm, A., White, C. & Pfleger, K. Erfassung der Internalisierung von GPCRs mit CRISPR/Cas9. Biospektrum 24, 616–617 (2018). https://doi.org/10.1007/s12268-018-0975-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-018-0975-9